Related Experiment Video

Updated: Nov 28, 2025

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

26.0K

Statin treatment and hypertrophic scarring after cardiac surgery

Camilla Chello1, Antonio Nenna2, Massimo Chello2

  • 1Department of Dermatology, Università La Sapienza di Roma, Rome, Italy.

Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society
|November 25, 2020
PubMed

Insights

Statins may reduce the formation of hypertrophic scars after cardiac surgery. This study found that statin use was associated with fewer scars, with higher doses offering more protection.

Area of Science:

  • Cardiovascular Surgery
  • Wound Healing
  • Pharmacology

Background:

  • Post-surgical wound healing is critical for preventing complications like infection.
  • Hypertrophic scars, often linked to inflammation, can arise after surgery, particularly cardiac procedures with significant inflammatory responses.
  • Statins possess anti-inflammatory properties beyond their lipid-lowering effects.

Purpose of the Study:

  • To investigate the effect of statins on the healing process and hypertrophic scar formation after median sternotomy in cardiac surgery patients.
  • To determine if statin use influences the incidence of hypertrophic scarring post-cardiac surgery.

Main Methods:

  • Retrospective review of 930 Caucasian patients undergoing major cardiac surgery with median sternotomy and cardiopulmonary bypass.
  • Evaluation of hypertrophic scar formation at outpatient visits post-discharge.
  • Logistic regression analysis to assess the association between statin use, age, and hypertrophic scarring.

Main Results:

  • Hypertrophic scars were observed in 29.7% of patients.
  • Younger age and non-statin use were significantly associated with hypertrophic scar formation.
  • Statin use demonstrated a protective role (odds ratio 0.39, P = .001), independent of age.
  • A dose-dependent protective effect of statins was identified, with higher doses showing greater efficacy.

Conclusions:

  • Statin use may be correlated with a reduced incidence of hypertrophic scars following median sternotomy in cardiac surgery.
  • The anti-scarring effect of statins appears to be dose-dependent and potentially independent of age in this patient population.
  • Further research is needed to elucidate the biological mechanisms underlying the anti-scarring potential of statins.

More Related Videos

A Mouse Model of Mechanotransduction-driven, Human-like Hypertrophic Scarring05:54

A Mouse Model of Mechanotransduction-driven, Human-like Hypertrophic Scarring

Published on: November 29, 2024

1.7K
A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

10.4K

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
197
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
108
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
191
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
86
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
135